Neurologic complications of COVID-19
Catherine Hassett, Aron Gedansky, Ibrahim Migdady, Adarsh Bhimraj, Ken Uchino, Sung‐Min Cho
Abstract
Patients with COVID-19 have a fairly high risk of neurologic complications, including encephalopathy, stroke, central nervous system infection, seizures, and neuromuscular diseases. Many report losing their senses of smell and taste, and many survivors report lingering neurocognitive impairment. The diagnosis and treatment of these complications does not differ from that in other patients, although sophisticated testing may not be readily available for a patient in intensive care and respiratory isolation. Clinicians should therefore be alert to these complications.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)EncephalopathyIntensive care medicineIsolation (microbiology)Stroke (engine)NeurocognitiveSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive carePediatricsDiseasePathologyInternal medicineBioinformaticsPsychiatryInfectious disease (medical specialty)Mechanical engineeringBiologyEngineeringOutbreakCognitionLong-Term Effects of COVID-19Intensive Care Unit Cognitive DisordersInfectious Encephalopathies and Encephalitis